Ping An Biomedical Enters Share Purchase Agreements with Multiple Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 09 2026
0mins
Ping An Biomedical has entered into a series of share purchase agreements with several investors: Yao Jinbo, Chairman and CEO of 58 Group; Wang Donghui, Founder and Managing Partner of Amiba Capital; and Li Daxue, Chairman and CEO of Magcloud Group and former Senior Vice President of JD.com and its Lifetime Honorary Advisor.
Analyst Views on PASW
About PASW
Ping An Biomedical Co Ltd, formerly known as Majestic Ideal Holdings Ltd, is an investment holding company mainly engaged in the provision of apparel supply chain management services (SCM services). The Company operates its business through two segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. The Company provides end-to-end supply chain solutions. The Company provides services covering functions within the supply chain of these products, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.








